Annual Drug Patent Expirations for VIZIMPRO
Vizimpro is a drug marketed by Pfizer and is included in one NDA. It is available from two suppliers. There are two patents protecting this drug.
This drug has fifty-one patent family members in forty-five countries.
The generic ingredient in VIZIMPRO is dacomitinib. Two suppliers are listed for this compound. Additional details are available on the dacomitinib profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
